Guochang Wang
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Development and Advantages of O-(Carboxymethyl)-L-tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer.
Journal: Journal of medicinal chemistry
Published: July 08, 2026
The Prognostic Value of 68Ga-PSMA and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-EB-PSMA.
Journal: Annals of nuclear medicine
Published: January 25, 2026
Design, Preclinical Evaluation, and Clinical Translation of [68Ga]Ga/[177Lu]Lu-JH120061, a Novel Radiopharmaceutical Targeting CXCR4.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 22, 2026
First-in-Human PET Imaging of Prostate Cancer Using [68Ga]Ga-AZ-093 and Its Nitroimidazole-Conjugated Derivative [68Ga]Ga-AZ-NI-093.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 23, 2025
Development of [68Ga]Ga/[177Lu]Lu-DOTA-NI-FAPI-04 Containing a Nitroimidazole Moiety as New FAPI Radiotracers with Improved Tumor Uptake and Retention.
Journal: Journal of medicinal chemistry
Published: December 23, 2024
Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68 Ga-HBED-CC-Exendin-4 in Localizing Insulinoma : A Head-to-Head Comparison to 68 Ga-NOTA-Exendin-4.
Journal: Clinical nuclear medicine
Published: November 05, 2024
Correction to: A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 05, 2024
Evaluation of Angiotensin-Converting Enzyme 2 Expression In Vivo with Novel 68Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding Domain.
Journal: ACS pharmacology & translational science
Published: May 28, 2024
A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 20, 2024
Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 09, 2024
68 Ga-FAPI-04 PET/CT in Assessment of Fibroblast Activation in Keloids : A Prospective Pilot Study.
Journal: Clinical nuclear medicine
Published: November 28, 2023
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 19, 2023
Last Updated: 09/26/2026